Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lens-Free Microscope Records Analyzable Optical Patterns

By LabMedica International staff writers
Posted on 23 Dec 2009
A lens-free microscope employs light to illuminate objects such as cells or pathogens in a sample, which create light diffraction and interference patterns that can be recorded by an optical detector.

The microscope, dubbed CyMap, was developed by Cancer Research UK (London, UK) scientists and members of the Optical Biochips Consortium. More...
It enables scientists to count the number of cells in a sample, and also to monitor changes over time, such as location, movement, and division. Because the system contains no physical lenses, there is no requirement for focusing or other critical adjustments.

CyMap has potential for use in medical diagnostics systems to quantify and analyze medical samples in hospitals, doctors' surgeries, and clinical laboratories. In addition, the technology could be developed into a compact cell-imaging system for use in research laboratories.

Dr Phil L'Huillier, Cancer Research Technology (CRT; London, UK) director of business management said: "We believe it can be used to cast light on key biological processes, or to develop new hand-held diagnostic devices. Although primarily designed to monitor the characteristics of cancer cells, the device has strong potential in a wide range of other health science fields."

The lens-free microscope won first prize in the Medical and Healthcare category at The Engineer awards. It also won the overall Grand Prix prize at the event, which focused on and celebrated technology and innovation. The 2009 Engineer awards were held at The Royal Society on December 4, 2009.

Related Links:

Cancer Research UK
Cancer Research Technology



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.